Sapio LIMS/ELN Provides NatureMetrics With a Configurable Workflow and Data Solution That Adapts as eDNA Technology Rapidly Evolves

Dante Labs launched Dante Labs Business, a new portal tailored for Healthcare Professionals and Researchers that combines the great genetics expertise of Dante Labs with the tailored needs of the private healthcare sector, academia and research.

1,000 patients will receive free whole genome sequencing and interpretation, including personalized reports, thanks to Epilepsy Awareness Day at Disneyland, in a push to advance new research and gene therapies

Will Be Honoring Leaders in Immunotherapy (Carl June, U Penn), CRISPR Technology (Feng Zhang, Broad Institute), Pharma (George D. Yancopoulos, Regeneron Pharmaceuticals) and Patient Research Advocacy (Sharon Terry, Genetic Alliance)

Harnessing the Power of Molecular Electronics to Revolutionize DNA Sequencing

Dante Labs introduced a new Whole Genome Sequencing of 130X coverage for the Exome and 30X coverage for DNA's non-coding regions

According to the new market research report launched by Inkwood Research, The Global CRISPR Market was valued around $ 500 million in 2017 and is anticipated to reach 8000 million by 2026, growing at an estimated CAGR of 36.53%, during the forecast period 2018-2026.

Strand NGS 3.0 release with processing improvements promise 2x speedup compared to the global benchmark

In recent years, some studies have found a close link between the intestinal microbes and the immune system, which provides a new way to improve the immune therapy by selectively modulating the intestinal bacteria.

Analysis results in greater understanding of important biological traits related to crop drought tolerance

Winners will be presented at the IMPACT conference on November 28 and 29 at the Ritz Carlton in Philadelphia

We are pleased to announce that we are changing our company name from PhyloTech to Second Genome.